Andrew Farlow

Andrew Farlow has worked for over 20 years in global health. Initially trained as an economist at Cambridge and Oxford, his highly interdisciplinary approach mixes biology, epidemiology, economics, finance, bioinformatics, management, ethics, and innovation studies. His positions and work at Oxford have ranged across departments: the Oxford Martin School, the Department of Biology, the Saïd Business School, the Nuffield Department of Medicine, and the Department of Economics. His recent research has covered emerging health technologies, equitable health finance (including pandemic finance), health system strengthening, malaria, TB, dengue, pandemic flu, antimicrobial resistance, climate change and health, early warning of disease outbreaks, and improved cost-effectiveness evaluation of new technologies such as AI. As chair of the Collaborations and Outreach Working Group of the ITU-WHO Focus Group on AI for Health (forerunner to the ITU-WHO-WIPO Global Initiative on AI for Health), Farlow has championed the role of LMICs in shaping a future of AI for health that prioritises their needs, with a strong focus, currently, on African innovators. He is a working group chair of the Coalition for Equitable Research in Health, represents Oxford on the European Global Health Research Institutes Network (EGHRIN), and chairs the Global Health Policy Partnership, which has been bringing together academics, practitioners, and policymakers from HICs and LMICs to share lessons and explore solutions to global health challenges in the areas of antimicrobial resistance, pandemic and epidemic preparedness, Digital and AI for Health, planetary health, and healthy aging. He has advised a wide range of public and private sector organizations, including the WHO, UNDP, TB Alliance, Stop TB, Aeras, JCVI, DFID, DNDi, the UK Treasury, Bill and Melinda Gates Foundation, World Bank, Oxfam, Médecins Sans Frontières, and Action Aid.